Curriculum vitae
- 1986 Degree in Chemistry – University of Milan
- 1988-1991 PhD – University of Milan
- 1992 Post-doc under the supervision of Prof. J. Bosch – University of Barcelona
- 1993 Researcher at the “Department of Chemistry” (University of Milan)
- 2006 Ass. Prof. of Organic Chemistry, University of Milan – Fac. Sc. Mat Fis. Nat.
- 2006 Collaborating Prof. Univ. Barcelona
- 2020 Full Professor of Organic Chemistry – University of Milan – Department of Chemistry
Teaching Activity in the field of Organic Chemistry, Organic Synthesis, Natural Products Chemistry
Research interests: in the field of Organic and Bioorganic Chemistry
- Preparation of quality collections of heterocyclic and natural compounds with biological interest
- New scaffolds for inhibitors of TK (cMet, Abl, Src), p53, HDAC, tubulin, sirtuins, topoisomerase I and II, hedgehog pathway
- Chemistry of Natural Products: Camptothecin, Podophillotoxin, Thiocolchicine, Colchicine, Evodiamine, Vinca Alkaloids (vincristine, vinblastine), Makaluvamine, Piperidine Alkaloids, Epothilone A
- Application of “Flow Chemistry” to “Medicinal Chemistry” and to the Synthesis of Natural Products
- Enatioselective synthesis of nitrogen containing compounds
- Preparation of hybrid compounds
- Multiple interaction with biological targets involved in the biology of cancer
- Preparation of prodrugs
- Dynamic Combinatorial Libraries
- Self-assembled nanoparticles for cancer treatment
- Hetero self-assembled nanoparticles for treatment of cancer stem cells
Scientific communications, seminars and courses
- Papers on international journals: 144 (Patents: 1)
- Conferences: 66
Coordinators of International projects:
- From 2019: Horizon 2020 MSCA-ITN-EJD (TubInTrain) “Tuning Tubulin Dynamics and Interactions to Face Neurotoxicity” – Project n. 860070
- MAECI Italia-India Strategic Projects 2017-2019 Title: “Development of bivalent antitubulin compounds” – Role: Italian Coordinator
- 2007-2011 Chair – COST Action CM 0602 Inhibitors of Angiogenesis: Design, Synthesis and Biological Exploitation
- 2012-2016 Chair – Cost Action CM 1106 Chemical Approaches to Targenting Drug Resistance in cancer Stem cells
Participation to ongoing Financed Projects:
- Telethon: Title: “Neuroserpin misfolding and FENIB neurodegeneration: mechanism and inhibition processes” – Role: Collaborator
- AIRC: Title: “Design and development of CDK2 and EGFR type III allosteric inhibitors as anticancer drugs” – Role: Responsible of the Milano UNIMI unit
- Prin2017: Title: “Identification, sustainable synthesis and study of molecular drugs efficacy in brain tumors treatment” – Role: Responsible of the Milano UNIMI unit
- FRRB: Title: New frontiers of engineered nanovectors to improve treatment efficacy and safety in neurological disorders (Nevermind) – Role: collaborator
Collaborations (synthesis, pharmacological evaluation, isolation of natural products, computational chemistry)
- National and International Research Institutions
- Pharmaceutical Companies